|
EMEA (European
Medicines Agency)
European Medicines Agency (EMEA) is a decentralised body of the
European Union with headquarters in London.
The EMEA began its activities in 1995, when the European
system for authorising medicinal products was introduced,
providing for a centralised and a mutual recognition
procedure. The EMEA has a role in both, but is primarily
involved in the centralised procedure. Where the centralised
procedure is used, companies submit one single marketing
authorisation application to the EMEA. A single evaluation
is carried out through the Committee for Medicinal Products
for Human Use (CHMP) or Committee for Medicinal Products for
Veterinary Use (CVMP). If the relevant Committee concludes
that quality, safety and efficacy of the medicinal product
is sufficiently proven, it adopts a positive opinion. This
is sent to the Commission to be transformed into a single
market authorisation valid for the whole of the European
Union.
Its main responsibility is the protection and promotion of
public and animal health, through the evaluation and
supervision of medicines for human and veterinary use. The
EMEA coordinates the evaluation and supervision of medicinal
products throughout the European Union. The Agency brings
together the scientific resources of the 25 EU Member States
in a network of 42 national competent authorities. It
cooperates closely with international partners, reinforcing
the EU contribution to global harmonisation.
The EMEA is headed by the Executive Director and has a
secretariat of about 360 staff members in 2004. The
Management Board is the supervisory body of the EMEA,
responsible, in particular, for budgetary matters.
In 2001, the Committee on Orphan Medicinal Products (COMP)
was established, charged with reviewing designation
applications from persons or companies who intend to develop
medicines for rare diseases (so-called ‘orphan drugs’). The
Committee on Herbal Medicinal Products (HMPC) was
established in 2004 and provides scientific opinions on
traditional herbal medicines.
|